Skip to main content
. 2010 Jan;11(1):1–9. doi: 10.1631/jzus.B0900295

Table 4.

Multivariate analyses of disease-free survival and overall survival using Cox’s proportional hazard models

Covariate Estimate Standard error Wald chi-square Hazard ratio P value
Disease-free survival (month)1
 Fractionated ER −0.13960 0.05628 6.1530 0.870 0.0131
 Fractionated PR −0.10107 0.05869 2.9655 0.904 0.0851
 Age <36 years 0.67577 0.29191 5.3592 1.966 0.0206
 Lymph node ≥10 1.35863 0.27997 23.5496 3.891 <0.0001
 Histology grade III 1.32154 0.61828 4.5687 3.749 0.0326
 AJCC stage 0.91674 0.18495 24.5675 2.501 <0.0001
Overall survival (month)2
 Fractionated PR −0.21830 0.06066 12.9512 0.804 0.0003
 Lymph node 1–9 0.81272 0.30782 6.9707 2.254 0.0083
 Lymph node ≥10 1.56278 0.33739 21.4549 4.772 <0.0001
 Histology grade III 0.68063 0.25213 7.2875 1.975 0.0069
 Tumor size (cm) 0.32670 0.16657 3.8469 1.386 0.0498
 Neoadjuvant or adjuvant chemotherapy 0.61693 0.35181 3.0750 1.853 0.0795
 Time lag since recurrence 0.07444 0.00775 92.2451 1.077 <0.0001
1

Cox’s proportional hazard model: n=416, adjusted generalized R 2=0.2486

2

Cox’s proportional hazard model: n=416, adjusted generalized R 2=0.3971